Assam: NRL Signs MoU with NIPER-Guwahati for Pharmaceutical Research

A CORRESPONDENT

BOKAKHAT: Numaligarh Refinery Limited (NRL) has entered into a strategic Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research, Guwahati (NIPER-G) on April 17 to collaborate on cutting-edge research aimed at deriving pharmaceutical-grade products and key drug intermediates from petroleum refinery based specialty chemicals. The MoU was signed at NRL’s corporate office in Guwahati by Dr USN Murty, Director of NIPER-G, and Bhaskar Jyoti Phukan, Managing Director of NRL. This collaboration is a significant step in leveraging refinery streams, particularly bio-based derivatives like furfural, for the synthesis of active pharmaceutical ingredients (APIs) such as furazolidone, nitrofurantoin, and furosemide. The joint effort will focus on green chemistry, reaction optimization, and scalable technologies for sustainable healthcare innovations. Speaking on the occasion, Dr Murty emphasized on the importance of such interdisciplinary collaborations for creating an indigenous pipeline of high-value pharmaceutical compounds. Phukan highlighted the strategic alignment of this partnership with NRL’s vision of becoming a leader in sustainable refinery innovation and expanding into value-added chemical domains. This MoU marks the beginning of a long-term collaboration aimed at fostering academic-industry synergy, promoting indigenous R&D, and contributing to India’s self-reliance mission in both the energy and pharmaceutical sectors.

Also Read: Assam: S Maharana assumes charge as NRL Director (Finance)

Also Watch: